Port Wine Stains
8
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Treatment Research
18 treatments under study, led by Nonmedicated Petroleum Cream
Research Leaders
10 sponsors active, led by Beckman Laser Institute University of California Irvine
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.5%
1 terminated out of 8 trials
83.3%
-3.3% vs benchmark
0%
0 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (8)
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients
Enhanced Efficacy Through Optimization of Hemoporfin-Photodynamic Therapy Parameters in Port-Wine Stains
Lip Reduction Surgery for Port-wine Macrocheilia
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
The Effects of Aldara as an Adjunct to Laser Treatment
Port Wine Stains Treatment Matrix RF Study
Research Network
Common Treatments
- Nonmedicated Petroleum Cream1
- Imiquimod1
- Matrix Rf1
- Pulsed Dye Laser 577 Nm1
- Irradiation At 84 Mwcm² For 17 Minutes Per Spot1
Active Sponsors
- Beckman Laser Institute University of California Irvine2
- University of California, Irvine2
- Aft Pharmaceuticals Limited1
- Henry Vasconez1
- Second Affiliated Hospital of Xi'an Jiaotong University1
Top Investigators
AFT Pharmaceuticals
University of Kentucky
Beckman Laser Institute University of California Irvine
University of Texas Southwestern Medical Center
Beckman Laser Institute University of California Irvine
Related Conditions
- Subjects Diagnosed With Port Wine Stains1